Floatz logo

Therapeutic Asset Ratings

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
hs-20093
Small Cell Lung Carcinoma
Shanghai Hansoh Biomedical Co., LtdP3BB (70)
Human Papillomavirus Serotype 58 Whole
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, IncP3BB (70)
Hydroxypropyl-Beta-Cyclodextrin
Niemann-Pick Disease, Type C1
Cyclo Therapeutics, Inc.P3BB (70)
Idarubicin
Childhood Acute Myeloid Leukemia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP3BB (70)
Idarubicin
Leukemia
Affiliated Hospital of Nantong UniversityP3BB (70)
Idarubicin
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer CenterP3BB (70)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Monoclonal Jmt101 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Jmt101 ?-Chain, Dimer
Non-Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P3BB (70)
Irinotecan
Adult Glioblastoma
NaviFUS CorporationP3BB (70)
Irinotecan
Digestive System Neuroendocrine Tumor, Grade 1/2
National Cancer Institute (NCI)P3BB (70)
Irinotecan
Ovarian Disorder
Xiaoxiang ChenP3BB (70)
Irinotecan
Breast Carcinoma
OHSU Knight Cancer InstituteP3BB (70)
Isocyclophosphamide
Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineP3BB (70)
Letrozole
Ovarian Serous Adenocarcinoma
Memorial Sloan Kettering Cancer CenterP3BB (70)
Linerixibat
Cholestasis
GlaxoSmithKlineP3BB (70)
L-Kappa-H-Gamma1 (Knob) Chain Anti-Dll3 (1-705) [L-Kappa Anti-Dll3 (1-214) [V-Kappa (Homo Sapiens Igkv1-17*03 (94.9%) -Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1-107) -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')] -38-Mer (Ggggse Gkssgsgses Kstegkssgs Gseskstggggs) Linker (215-252) -H-Gamma-1 Heavy Chain Anti-Dll3 (253-705) [Vh (Homo Sapiens Ighv1-46*01 (92.9%) -(Ighd) -Ighj6*01 (94.7%), Cdr-Imgt [8.8.17] (278-285.303-310.349-365)) (253-376)-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V32 Ch3 W22 (Knob) (Ch1 R120 (473) (377-474), Hinge 1-15 (475-489), Ch2 L1.3>A (493), L1.2>A (494) (490-599), Ch3 E12 (615), M14 (617), T22>W (625) (600-704), Chs K2>Del (705)) (377-705)]]; L-Lambda6-H-Gamma1 (Hole) Chain Anti-Cd3E (1-707) [L-Lambda6 Anti-Cd3 (1'-215') [V-Lambda Musmus/Homsap (Mus Musculus Iglv1*01 (82.3%) -Iglj1*01 (100%)/Homo Sapiens Iglv7-46*01 (76.8%) -Iglj3*02 (100%), Cdr-Imgt [9.3.9] (26'-34'.52'-54'.91'-99')) (1'-109') -Homo Sapiens Iglc6*01 (100%) (110'-215')] -38-Mer (Ggggse Gkssgsgses Kstegkssgsgseskstggggs) Linker (216'-253') -H-Gamma-1 Anti-Cd3E (254'-707') [Vh Musmus/Homsap (Mus Musculus Ighv10-1*02 (92.9%) -(Ighd) -Ighj3*01 (100%)/Homo Sapiens Ighv3-73*01 (87.0%) -(Ighd) -Ighj6*01 (81.8%) T123>L (373'), S128>A (378'), Cdr-Imgt [8.10.16] (279'-286'.304'-313'.352'-367')) (254'-378')-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V33 Ch3 S22, A24, V86 (Hole), G1V83 Ch3 R115, F116 (Ch1 R120 (475') (379'-476'), Hinge 1-15 (477'-491'), Ch2 L1.3>A (495'), L1.2>A (496') (492'-601'), Ch3 E12 (617'), M14 (619'), T22>S (627'), L24>A (629'), Y86>V (686'), H115>R (696'), Y116>F (697') (602'-706'), Chs K2>Del (707')) (379'-707')]]; Dimer (485-487':488-490')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Small Cell Lung Carcinoma
Boehringer IngelheimP3BB (70)
Melphalan
Disease Related To Hematopoietic Stem Cell Transplant
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (70)
Mercaptopurine Anhydrous
Leukemia
Dana-Farber Cancer InstituteP3BB (70)
Methotrexate
Acute Undifferentiated Leukemia
Therapeutic Advances in Childhood Leukemia ConsortiumP3BB (70)
Methotrexate
Disease Related To Hematopoietic Stem Cell Transplant
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)P3BB (70)
Methotrexate
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Novartis PharmaceuticalsP3BB (70)
Methotrexate
Childhood Myelodysplastic Syndrome
Children's Oncology GroupP3BB (70)
Methotrexate
Graft Versus Host Disease
University of Michigan Rogel Cancer CenterP3BB (70)
Methotrexate
Plasma Cell Myeloma
Poseida Therapeutics, Inc.P3BB (70)
Mevrometostat
Castration-Resistant Prostate Carcinoma
Prostate Cancer Clinical Trials ConsortiumP3BB (70)
Mirvetuximab Soravtansine
Fallopian Tube Cancer
AbbVieP3BB (70)
Showing 1501 to 1525 of 42,327 assets
PreviousPage 61 of 1694Next